theophylline has been researched along with n-benzo(1,3)dioxol-5-yl-2-(5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1h-purin-8-yl)-1-methyl-1h-pyrazol-3-yloxy)-acetamide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG; Benini, A; Borea, PA; Cattabriga, E; Gessi, S; Klotz, KN; Lennan, SM; Leung, E; Merighi, S; Tabrizi, MA; Varani, K; Vincenzi, F | 1 |
| Baraldi, PG; Baskin, II; Ivanov, AA; Palyulin, VA; Piccagli, L; Zefirov, NS | 1 |
| Bertarelli, DC; Borrmann, T; Florin, NC; Hinz, S; Li, W; Müller, CE; Scheiff, AB | 1 |
| Cheng, F; Liu, G; Tang, Y; Xu, Z | 1 |
| Azuaje, J; Carbajales, C; Crespo, A; El Maatougui, A; Escalante, L; García-Mera, X; González-Gómez, M; Gutiérrez-de-Terán, H; Miguez, G; Sotelo, E | 1 |
| Barawkar, DA; Basu, S; Bedse, G; Bonagiri, R; Chaturvedi, S; Chugh, A; Dusange, S; Ghosh, I; Goswami, A; Gundu, J; Jadhav, D; Karande, V; Kulkarni, A; Kumar, S; Menon, S; Mookhtiar, KA; Mukhopadhyay, P; Paliwal, S; Palle, VP; Panmand, A; Patel, M; Prasad, V; Quraishi, A; Ramdas, V; Reddy, BS; Rouduri, S; Thakre, R; Thorat, S; Waman, Y | 1 |
| Gaba, S; Gupta, GD; Monga, V; Patel, R; Saini, A; Singh, G | 1 |
1 review(s) available for theophylline and n-benzo(1,3)dioxol-5-yl-2-(5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1h-purin-8-yl)-1-methyl-1h-pyrazol-3-yloxy)-acetamide
| Article | Year |
|---|---|
Adenosine receptor antagonists: Recent advances and therapeutic perspective.
Topics: Dose-Response Relationship, Drug; Humans; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Structure-Activity Relationship | 2022 |
6 other study(ies) available for theophylline and n-benzo(1,3)dioxol-5-yl-2-(5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1h-purin-8-yl)-1-methyl-1h-pyrazol-3-yloxy)-acetamide
| Article | Year |
|---|---|
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Binding, Competitive; Cell Line; Cyclic AMP; Humans; Molecular Structure; Protein Binding; Receptor, Adenosine A2B; Recombinant Proteins | 2005 |
Molecular modeling and molecular dynamics simulation of the human A2B adenosine receptor. The study of the possible binding modes of the A2B receptor antagonists.
Topics: Adenosine A2 Receptor Antagonists; Amino Acid Sequence; Binding Sites; Computer Simulation; Humans; Lipid Bilayers; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Phospholipids; Receptor, Adenosine A2B; Water | 2005 |
1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.
Topics: Adenosine A2 Receptor Antagonists; Animals; Drug Design; Humans; Kinetics; Ligands; Mice; Protein Binding; Radioligand Assay; Rats; Receptor, Adenosine A2B; Xanthines | 2009 |
Insights into binding modes of adenosine A(2B) antagonists with ligand-based and receptor-based methods.
Topics: Adenosine A2 Receptor Antagonists; Amino Acid Sequence; Drug Discovery; Humans; Ligands; Models, Molecular; Molecular Conformation; Molecular Sequence Data; Protein Binding; Receptor, Adenosine A2B; Reproducibility of Results; Sequence Homology, Amino Acid | 2010 |
Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes.
Topics: Adenosine A2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Structure; Pyrimidinones; Receptor, Adenosine A2B; Structure-Activity Relationship | 2016 |
A
Topics: Adenosine A2 Receptor Antagonists; Animals; Brain; Chemistry Techniques, Synthetic; Drug Design; Male; Mice; Receptor, Adenosine A2B; Structure-Activity Relationship; Xanthine | 2017 |